4//SEC Filing
RAUSCHER STEVEN M 4
Accession 0001209191-17-047303
CIK 0001008848other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 4:08 PM ET
Size
9.0 KB
Accession
0001209191-17-047303
Insider Transaction Report
Form 4
RAUSCHER STEVEN M
Director
Transactions
- Exercise/Conversion
Common Stock
2017-08-01$18.21/sh+10,000$182,100→ 10,000 total - Exercise/Conversion
Non-Employee Stock Option
2017-08-01−10,000→ 0 totalExercise: $18.21Exp: 2017-08-06→ Common Stock (10,000 underlying) - Sale
Common Stock
2017-08-01$21.57/sh−10,000$215,703→ 0 total
Footnotes (3)
- [F1]Exercise and sales pursuant to a 10b5-1 plan. The exercised options were scheduled to expire in 2017 on the expiration date reported within Table II unless exercised.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $21.30 to $21.95 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The shares subject to these options vested in installments and were fully vested on 06/05/2008.
Documents
Issuer
ACORDA THERAPEUTICS INC
CIK 0001008848
Entity typeother
Related Parties
1- filerCIK 0001166683
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 4:08 PM ET
- Size
- 9.0 KB